Forging a path for MedTech Innovation.
Executive Vice President Global, Strategy and Analysis, AdvaMed


Executive Vice President Global, Strategy and Analysis, AdvaMed
Chief Executive Officer, MedTech Europe
President & CEO, Medtech Canada
Director, Business Development, IQVIA MedTech
MedTech in Flux: Navigating Global Disruption
The MedTech industry is at a critical juncture with the global impact of U.S. tariffs and shifting trade dynamics. Hosted by IQVIA MedTech and featuring expert insights from regional trade associations AdvaMed, MedTech Canada and MedTech Europe - this webinar provides valuable insights into the global risks of U.S. tariffs and shifting trade dynamics on MedTech, and strategies medical device companies can adopt to mitigate these risks.
See video timecodes below:
00:00:00 – Webinar Introduction
Matt Stewart opens the webinar by introducing our speakers and the context for the webinar.
00:02:17 – MedTech Sector recent challenges
Ashley Miller, Nicole DeKort, and Oliver Bisazza begin the conversation by discussing the approach to tariffs by the U.S, Canada and the EU, the uncertainties, and the potential downstream effects.
00:07:31 – The impact of tariffs on medical device companies
Our panel explores why tariffs have more of a direct and immediate impact on medical device companies compared to the pharmaceutical industry.
00:14:00 – Key concerns driving the need for medical device tariff exemptions
Our panel call for “zero-for-zero” tariff agreements in MedTech and explain the reasons for why this is so important.
00:29:12 – Strategies for mitigating risks
In this section we explore the projected cost of tariffs on the MedTech industry, which countries will be impacted the most, and the actions that need to be taken now to navigate the disruption.
You can download the presentation here.
If you wish to speak with our IQVIA MedTech team, please click the “CONTACT US” button floating on this page to make an enquiry.
Forging a path for MedTech Innovation.
Connected commercial solutions, maximizing market performance.